Skip to content
  • News
  • Events
  • Lists
  • Life
  • Magazine
  • 30 Under 30
  • Sign-in
  • Subscribe

Bio tech

Brandon Capital Chris Nave

Brandon Capital’s $60m taypayer-funded biotech bets

Around $60 million in taxpayer funds has been deployed by Brandon Capital to startups working on cancer cures, infection prevention, fibrosis treatment and more. Brandon Capital has deployed around $60 million of National Reconstruction Fund capital across 10 biotech startups over the past year, championing the NRF as helping to keep promising technology in the […]

  • By Daniel Van Boom
  • Business Journalist

$65 million CSL-backed biotech incubator on the hunt for Aussie start-ups

A new biotech incubator in Melbourne, the Jumar Bioincubator, operated by Cicada Innovations, has put a call-out to early stage start-ups looking to scale their ventures.

  • By Anastasia Santoreneos
  • Journalist & List Editor

Exclusive: Mark Zuckerberg and Priscilla Chan on their next billion dollar plan

In a rare interview, the Meta Platforms CEO and his pediatrician wife, who are co-CEOs of the Chan Zuckerberg Initiative, discuss their plans to use technology to deepen understanding of human cells and tissues—and the impact they want it to have on human health.

  • By Kerry A. Dolan
  • Forbes Staff
Photos are by Dan Wilkins and Rebecca Mcwatters of the Environmental stewardship programme at the Australian Antarctic Division.

Australian research seeking solutions for Antarctic diesel spills

Diesel spills can disrupt local ecology with long-lasting effects.

  • By Elise Shaw
  • Digital Editor

Asides

Jay Horvat is an Associate Professor in Immunology and Microbiology working for HMRI at the University of Newcastle

How science research can educate business leaders

Hierarchy can be a scaffold for career growth or a harness that holds back creative thinking.

  • By Elise Shaw
  • Digital Editor

Fertility device aims to revolutionise IVF treatment

The Fertilis devices improve the quality and quantity of embryos.

  • By Elise Shaw
  • Digital Editor

Aravax secures US$20 million Series B funding for peanut allergy therapy

Aravax’s novel platform technology has potential application against other allergens.

  • By Elise Shaw
  • Digital Editor
Dr Daniel Mediati, a scientist in the School of Biotechnology and Biomolecular Sciences at the University of New South Wales

Australian researchers discover bacterial mechanism that confers a survival tactic putting patient lives at risk

Golden Staph is one of the major infectious diseases threatening hospitals in Australia.

  • By Elise Shaw
  • Digital Editor
Dr Pip Karoly and team at Seer Medical working on the app

How technology can help you understand your biological rhythms

It is so valuable to put the power of people’s own health data and their health outcomes into their own hands.

  • By Elise Shaw
  • Digital Editor
Elizabeth Holmes Attends Court Hearing As She Motions For New Trial

Elizabeth Holmes asks for only 18 months in prison after guilty verdict

Over 130 people, including former Theranos employees and investors, submitted letters to the court in Holmes’ support, her lawyers said.

  • By Marisa Dellatto
  • Forbes Staff
1 2 Older Posts
We use cookies to help us to deliver our services and provide personalised experiences. By using this website you agree to use our cookies. Cookie Policy

The best of Forbes, delivered to your inbox

I accept Forbes Australia's Terms and Privacy Policy

All set

Please check your inbox to confirm your subscription. Welcome to the Forbes community

 

  • Sections
    • News
    • Events
    • Lists
    • Life
  • Company
    • About us
    • Contact us
    • Careers
    • Advertise with Forbes Australia
    • Media
    • FAQ
  • Explore
    • Billionaires
    • Entrepreneurs
    • Innovation
    • Leadership
Social
  • Facebook
  • LinkedIn
  • Instagram
  • Twitter
  • YouTube

Magazines covers

Get the magazine delivered with a Premium membership, find it at all good newsagents, or purchase previous issues online.

© 2026 Success Publishing Pty Ltd including content reproduced under license from Forbes IP (HK) LTD. All Rights Reserved.
  • Privacy Policy
  • Terms of use
  • News
  • Events
  • Lists
  • Life
  • Magazine
  • 30 Under 30
  • Sign-in
  • Subscribe